Filing Details
- Accession Number:
- 0001209191-14-068620
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-11-13 18:15:37
- Reporting Period:
- 2014-11-10
- Filing Date:
- 2014-11-13
- Accepted Time:
- 2014-11-13 18:15:37
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1478242 | Quintiles Transnational Holdings Inc. | Q | Services-Commercial Physical & Biological Research (8731) | 271341991 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1108988 | 3I Corp | One Grand Central Place 60 E 42Nd Street, Suite 4100 New York NY 10165 | No | No | Yes | No | |
| 1507999 | 3I U.s. Growth Corp | One Grand Central Place 60 E 42Nd Street, Suite 4100 New York NY 10165 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2014-11-10 | 2,463,203 | $58.09 | 9,758,385 | No | 4 | S | Indirect | See Footnote |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | See Footnote |
Footnotes
- 3i U.S. Growth Corporation is the general partner of funds that directly own the reported securities. 3i Corporation is the manager of funds that directly own the reported securities. Investment and divestment decisions are made by the board of directors of 3i Corporation, which is an indirect wholly owned subsidiary of 3i Group plc, a public company listed on the London Stock Exchange. As a result, 3i Corporation, as manager of each of the funds, and 3i U.S. Growth Corporation, as general partner of each of the funds, may be deemed to have voting and dispositive power with respect to the shares of common stock held by the managed funds.
Billionaire Hedge Funds
